AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”

Hospital Groups Urge Federal Court to Uphold Maryland’s 340B Contract Pharmacy Access Law

July 2, 2024 Shannon Young, Associate Editor/Senior Writer Views

Groups representing Maryland providers along with national advocacy groups recently urged a federal judge to reject Novartis’ attempt to block [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!